Despite experimental evidence implicating IL-8/CXCR2 axis and SOCS-3 in the progression of RCC, in situ characterization of their expression by RCC cells and its clinical relevance has not thus far been performed. This evidence concerns the gene SOCS3 and renal cell carcinoma.